Skip to main content

Abridge

Category: AI in Healthcare

An AI-powered platform that records and transforms patient-clinician conversations into structured, summarized clinical notes directly within the electronic health record (EHR). Abridge was founded in 2018. The company is led by Dr. Shivdev Rao. Based in Pittsburgh, Pennsylvania, USA. Team size: 435-522. Total funding raised: $757.5M. Latest round: Series E ($300M, Jun 2025 at $5.3B valuation led by a16z and Khosla). Key investors include Lightspeed Venture Partners, Redpoint Ventures, IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Andreessen Horowitz (a16z), Khosla Ventures, Kaiser Permanente Ventures, CVS Health Ventures, CapitalG, NVentures (NVIDIA), Elad Gil, California Health Care Foundation.

Founded
2018
Headquarters
Pittsburgh, Pennsylvania, USA
Team size
435-522
Total funding
$757.5M

Value proposition

To reduce physician burnout and administrative burden by automating clinical documentation, thereby saving time, improving note accuracy, and allowing clinicians to focus more on patient care.

Products and solutions

AI-driven medical conversation transcription and summarization, Deep, native integration with EHR systems like Epic, Automated creation of structured clinical notes, Patient-friendly summaries of medical conversations

Unique value

Abridge's core innovation lies in its ability to not just transcribe, but to use proprietary AI models to understand medical conversations and generate structured, clinically relevant summaries that integrate seamlessly into existing EHR workflows.

Target customer

Physicians, clinicians, hospitals, and large enterprise health systems.

Industries served

Healthcare

Technology advantage

Its key advantage is the deep, native integration with major EHRs like Epic ('Abridge Inside'), which simplifies adoption and workflow. The company's focus on large, enterprise-level partnerships with major health systems provides a significant data advantage for training its AI models and a strong distribution channel.

How they differentiate

Abridge differentiates itself through its deep, native-like EHR integration, an enterprise-first sales strategy targeting entire health systems, and an AI-only workflow that avoids a 'human-in-the-loop' for scalability. It competes on both workflow automation and the creation of structured, high-quality clinical documentation rather than just transcription.

Main competitors

Nuance Communications (a Microsoft company, offering DAX Copilot), Suki.AI, Nabla

Key partnerships

Epic (for deep EHR integration), Partnerships with numerous major health systems for deployment and data collaboration.

Notable customers

Kaiser Permanente, Mayo Clinic, UPMC, Yale New Haven Health System, Johns Hopkins Health System, Duke Health, Sutter Health, CHRISTUS Health, Corewell Health, Deaconess Health System, Emory Healthcare, Reid Health, UChicago Medicine, The University of Kansas Health System, University of Vermont Health Network, AltaMed Health Services, Sharp HealthCare, Seattle Children's Hospital

Major milestones

2018: Company founded. February 2024: Raised $150M in Series C funding at an $850M valuation. February 2025: Raised $250M in Series D funding at a $2.75B valuation. June 2025: Secured $300M in Series E funding at a $5.3B valuation led by Andreessen Horowitz. April 2026: Raised $316M Series E extension. May 2026: Named San Oo as CTO.

Growth metrics

Deployed in over 270 health systems and expected to support over 100 million patient conversations in 2026.

Market positioning

Positioned as a high-growth leader in the generative AI for healthcare market, competing directly with major players like Microsoft/Nuance for large enterprise contracts with a focus on deep workflow integration.

Geographic focus

Primarily the United States healthcare market.

Patents and IP

Specific patents are not publicly listed, but the company's primary intellectual property is its proprietary, multimodal AI and NLP foundation models trained exclusively on healthcare data.

About Dr. Shivdev Rao

Dr. Shivdev Rao is the Founder and CEO of Abridge, a healthcare AI company that structures and summarizes medical conversations. He is also a practicing cardiologist at UPMC’s Heart and Vascular Institute. Before founding Abridge, he was the Executive Vice President at UPMC Enterprises, where he managed technology investments and R&D. He has been recognized as one of Time's 100 Most Influential People in AI.

Official website: